Tessa Therapeutics to build commercial-scale facility for VST therapies
A Singapore biotech that has been manufacturing virus-specific T cells for its clinical studies is ready to scale up. Tessa Therapeutics will build a 90,000 square foot global cell therapy manufacturing facility in Singapore. Tessa Therapeutics, which is developing cell therapies to treat cancer, expects to have the facility complete by year-end 2020. It will be… Read More »